Company Filing History:
1 out of 1,361 
1 out of 282 
Years Active: 2022
Title: Alisa Dong: Innovator in Hemoglobinopathy Therapy
Introduction
Alisa Dong is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of gene therapy, particularly in the treatment of hemoglobinopathies. Her innovative work has led to the development of a patent that addresses critical medical challenges.
Latest Patents
Alisa Dong holds a patent for "Viral vectors for prophylaxis and therapy of hemoglobinopathies." This patent provides compositions and methods for inducing expression of human beta-globin in erythrocytes for use in prophylaxis and/or therapy of hemoglobinopathy in an individual. The method involves introducing into CD34+ cells a poly-nucleotide encoding several essential components, including a 5' long terminal repeat (LTR) and a self-inactivating 3' LTR, among others. The invention aims to improve the treatment options available for individuals suffering from hemoglobinopathies.
Career Highlights
Throughout her career, Alisa Dong has worked with esteemed institutions such as Cornell University and The Children's Hospital of Philadelphia. Her research has focused on developing innovative solutions to complex medical issues, particularly in the realm of genetic disorders.
Collaborations
Alisa has collaborated with notable colleagues, including Stefano Rivella and Laura Breda. These partnerships have further enhanced her research and contributed to advancements in the field of gene therapy.
Conclusion
Alisa Dong's work exemplifies the impact of innovation in medicine, particularly in the treatment of hemoglobinopathies. Her contributions continue to pave the way for future advancements in gene therapy and patient care.